BU-NOT-SET

CONTACT US
Nitrosamines analysis
  • Analytical chemistry
Nitrosamines analysis
Fact sheet
Enabling oral solid dosage form delivery of biologics
  • Biologics
  • Drug substance
oral biologics
Insight
Plasmid DNA manufacturing capabilities
  • Biologics
plasmid DNA manufacturing
Fact sheet
Leveraging analytics throughout development and manufacture to achieve commercial success
  • Analytical chemistry
  • Drug substance
development
Insight
2,300 solar panels installed at Recipharm’s Holmes Chapel
  • Sustainability
solar panels
Insight
Analysing prebiotic oligosaccharides for future product innovation
  • Analytical chemistry
  • Drug substance
Workers
White paper
Enhancing sterile processing for future vaccine programs
  • Industry trends
  • Manufacturing
Manufacturing
Insight
Increasing carbon emission transparency through SBTi contributions
  • Sustainability
SBTi
Insight
Single-use technologies are enabling increasing demand for biologics
  • Biologics
People
Insight
Insight
  • Biologics
Unlocking the potential of RNA therapeutics through innovation and collaboration
White paper
  • Analytical chemistry
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
Insight
  • Biologics
Enhancing the production of RNA with continuous manufacturing
Fact sheet
  • Drug product
GERTEIS MINI-PACTOR® Advanced dry granulation services
Case study
  • Biologics
Overcoming oncolytic virus therapy production challenges through collaboration
Insight
  • Industry trends
Emerging trends set to impact drug development in 2024
Webinar
  • Biologics
Webinar: ATMPs in focus: Essential CMC strategies for every phase
Insight
  • Drug product
  • Industry trends
Trends set to make an impact on oral solid dose development in 2024
Insight
  • Biologics
Enhancing AAV therapy development and manufacture with a platform approach